Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2018
Patient-assisted compression helps for image quality reduction dose and improves patient experience in mammography
Corinne Balleyguier, Morgane Cousin, Ariane Dunant, et al.
Scientific Reports
|
May 10, 2019
Raptor talon shape and biomechanical performance are controlled by relative prey size but not by allometry
Leah R Tsang, Laura A B Wilson, Justin Ledogar, et al.
Gland Surgery
|
March 4, 2022
Preoperative ultrasound mapping of the vagus nerve in thyroid surgery
Sophie Bidault, Elizabeth Girard, Marie Attard, et al.
Endocrine-Related Cancer
|
October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview
Clotilde Sparano, Yann Godbert, Marie Attard, et al.
Plos One
|
December 25, 2013
Micro-biomechanics of the Kebara 2 hyoid and its implications for speech in Neanderthals
Ruggero D'Anastasio, Stephen Wroe, Claudio Tuniz, et al.
European Journal of Endocrinology
|
April 22, 2021
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?
Livia Lamartina, Sophie Bidault, Julien Hadoux, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment
Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
JCO Precision Oncology
|
December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
Lancet (London, England)
|
February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Eric Baudin, Bernard Goichot, Alfredo Berruti, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2018
Patient-assisted compression helps for image quality reduction dose and improves patient experience in mammography
Corinne Balleyguier, Morgane Cousin, Ariane Dunant, et al.
Scientific Reports
|
May 10, 2019
Raptor talon shape and biomechanical performance are controlled by relative prey size but not by allometry
Leah R Tsang, Laura A B Wilson, Justin Ledogar, et al.
Gland Surgery
|
March 4, 2022
Preoperative ultrasound mapping of the vagus nerve in thyroid surgery
Sophie Bidault, Elizabeth Girard, Marie Attard, et al.
Endocrine-Related Cancer
|
October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview
Clotilde Sparano, Yann Godbert, Marie Attard, et al.
Plos One
|
December 25, 2013
Micro-biomechanics of the Kebara 2 hyoid and its implications for speech in Neanderthals
Ruggero D'Anastasio, Stephen Wroe, Claudio Tuniz, et al.
European Journal of Endocrinology
|
April 22, 2021
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?
Livia Lamartina, Sophie Bidault, Julien Hadoux, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment
Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
JCO Precision Oncology
|
December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
Lancet (London, England)
|
February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Eric Baudin, Bernard Goichot, Alfredo Berruti, et al.
Page
of 1